A decades-old mystery of how natural antimicrobial predatory bacteria are able to recognize and kill other bacteria may have been solved, according to new research.
In a study published in Nature Microbiology, researchers from the University of Birmingham and the University of Nottingham have discovered how natural antimicrobial predatory bacteria, called Bdellovibrio bacterivorous, produce fiber-like proteins on their surface to ensnare prey.
This discovery may enable scientists to use these predators to target and kill problematic bacteria that cause issues in healthcare, food spoilage, and the environment.
Professor of Structural Biology at the University of Birmingham, Andrew Lovering said: "Since the 1960s Bdellovibrio bacterivorous has been known to hunt and kill other bacteria by entering the target cells and eating them from the inside before later bursting out. The question that had stumped scientists was 'how do these cells make a firm attachment when we know how varied their bacterial targets are?'"
Professor Lovering and Professor Liz Sockett, from the School of Life Sciences at the University of Nottingham, have been collaborating in this field for almost 15 years. The breakthrough came when Sam Greenwood an undergraduate student, and Asmaa Al-Bayati, a PhD student in the Sockett lab, discovered that the Bdellovibrio predators lay down a sturdy vesicle (a "pinched-off" part of the predator cell envelope) when invading their prey.
The Role of Vesicles and Fibers in Predation
Professor Liz Sockett explained: "The vesicle creates a kind of airlock or keyhole allowing Bdellovibrio entry into the prey cell. We were then able to isolate this vesicle from the dead prey, which is a first in this field. The vesicle was analyzed to reveal the tools used during the preceding event of predator/prey contact. We thought of it as a bit like a locksmith leaving the pick, or key, as evidence, in the keyhole.
"By looking at the vesicle contents, we discovered that because Bdellovibrio doesn't know which bacteria it will meet, it deploys a range of similar prey recognition molecules on its surface, creating lots of different 'keys' to 'unlock' lots of different types of prey."
Advanced Molecular Analysis and Engineering
The researchers then undertook an individual analysis of the molecules, demonstrating that they form long fibers, approximately ten times longer than common globular proteins. This allows them to operate at a distance and "feel" for prey in the vicinity.
In total, the labs counted 21 different fibers. Researchers Dr Simon Caulton, Dr Carey Lambert, and Dr Jess Tyson worked on how they operated both at the cellular and molecular levels. They were supported by fibre gene-engineering by Paul Radford and Rob Till. The team then began to attempt linking a particular fiber to a particular prey-surface molecule. Finding out which fiber matches which prey, could enable an engineering approach that sees bespoke predators targeting different types of bacteria.
Professor Lovering continued: "Because the predator strain we were looking at comes from the soil it has a wide killing range, making this identification of these fiber and prey pairs very difficult. However, on the fifth attempt to find the partners we discovered a chemical signature on the outside of prey bacteria that was a tight fit to the fibre tip. This is the first time a feature of Bdellovibrio has been matched to prey selection."
Scientists in this field will now be able to use these discoveries to ask which fiber set is used by the different predators they study and potentially attribute these to specific prey. Improving understanding of these predator bacteria could enable their usage as antibiotics, to kill bacteria that degrade food, or ones that are harmful to the environment.
Professor Lovering concluded: "We know that these bacteria can be helpful, and by fully understanding how they operate and find their prey, it opens up a world of new discoveries and possibilities."
Reference: "Bdellovibrio bacteriovorus uses chimeric fibre proteins to recognize and invade a broad range of bacterial hosts" by Simon G. Caulton, Carey Lambert, Jess Tyson, Paul Radford, Asmaa Al-Bayati, Samuel Greenwood, Emma J. Banks, Callum Clark, Rob Till, Elisabete Pires, R. Elizabeth Sockett and Andrew L. Lovering, 4 January 2024, Nature Microbiology.
DOI: 10.1038/s41564-023-01552-2
The research was funded by the Wellcome Trust Investigator in Science Award (209437/Z/17/Z).
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]















